Unknown cellular components

The term "Unknown cellular components" is a placeholder designation used in pharmacological databases, such as ChEMBL, to categorize drugs or chemical entities whose specific molecular targets have not been identified or characterized (Gaulton et al., 2012). It does not refer to a specific biological entity, such as a protein or enzyme, but rather indicates a gap in the current understanding of a compound's mechanism of action. This designation is common for substances discovered through phenotypic screening, where a biological effect is observed in a whole-cell or organismal system without prior knowledge of the target (Moffat et al., 2017). Because the term is a generic category, it does not have inherent biological functions, molecular classifications, or specific roles in disease pathology. In the context of drug development, compounds associated with unknown targets pose significant challenges, as their safety profiles and potential off-target effects are difficult to predict (Ziegler et al., 2013). Identifying the precise molecular interaction, a process known as target deconvolution, is essential for optimizing the therapeutic index and advancing a drug candidate through regulatory approval. Therefore, "Unknown cellular components" serves as a temporary label until further research elucidates the underlying molecular biology of the drug's effect.

The mechanism of action is unknown or has not been characterized at the molecular level.